| |
| |
|
| Insider
Information: |
Carter Bruce L A |
| Relationship: |
|
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
183,977 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,050,695 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
183,977 |
|
|
| Total
Value |
$1,050,695 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 56.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zymogenetics Inc |
ZGEN |
Director |
2010-10-08 |
115,399 |
2004-06-21 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2009-05-14 |
20,000 |
2009-05-14 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2015-04-13 |
0 |
2015-04-13 |
0 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2017-06-14 |
48,578 |
2015-06-15 |
0 |
Premium* |
|
|
Enanta Pharmaceuticals Inc |
ENTA |
Director |
2022-03-21 |
0 |
2019-02-11 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2019-02-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZGEN |
Zymogenetics Inc |
CEO & Chairman of the Board |
• • – |
2008-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
100 |
147,149 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,475 |
3,475 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,546 |
6,021 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,444 |
10,465 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Director |
– • – |
2023-12-29 |
4 |
A |
$58.75 |
$399,970 |
D/D |
6,808 |
17,273 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
President & CEO |
• • – |
2005-02-14 |
4 |
AS |
$19.55 |
$488,875 |
D/D |
(25,000) |
131,299 |
|
- |
|
| ZGEN |
Zymogenetics Inc |
President & CEO |
• • – |
2005-05-17 |
4 |
AS |
$18.00 |
$450,000 |
D/D |
(25,000) |
131,299 |
|
- |
|
| ZGEN |
Zymogenetics Inc |
officerTitle |
• • – |
2006-01-09 |
4 |
AS |
$19.92 |
$498,000 |
D/D |
(25,000) |
131,299 |
|
- |
|
| ZGEN |
Zymogenetics Inc |
President & CEO |
• – – |
2006-08-24 |
4 |
AS |
$20.04 |
$501,000 |
D/D |
(25,000) |
131,299 |
|
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-02-11 |
4 |
AS |
$90.02 |
$246,102 |
D/D |
(2,734) |
0 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-02-12 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-02-20 |
4 |
AS |
$72.50 |
$220,921 |
D/D |
(3,000) |
0 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-03-11 |
4 |
AS |
$99.16 |
$153,301 |
D/D |
(1,546) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-05-22 |
4 |
AS |
$75.20 |
$225,597 |
D/D |
(3,000) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-08-21 |
4 |
AS |
$89.24 |
$267,720 |
D/D |
(3,000) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2019-11-20 |
4 |
AS |
$94.74 |
$284,220 |
D/D |
(3,000) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-08-11 |
4 |
AS |
$125.78 |
$284,428 |
D/D |
(2,250) |
2,000 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2020-12-14 |
4 |
AS |
$240.93 |
$554,127 |
D/D |
(2,250) |
2,000 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
|
– • – |
2021-02-02 |
4 |
AS |
$190.50 |
$430,018 |
D/D |
(2,250) |
3,475 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2022-03-21 |
4 |
AS |
$66.70 |
$406,970 |
D/D |
(6,000) |
0 |
0 |
% |
|
| ZGEN |
Zymogenetics Inc |
CEO & Chairman of the Board |
• • – |
2007-08-03 |
4 |
B |
$12.56 |
$197,847 |
D/D |
15,750 |
147,049 |
2.81 |
- |
|
| ZGEN |
Zymogenetics Inc |
CEO & Chairman of the Board |
• • – |
2008-02-19 |
4 |
B |
$9.13 |
$100,462 |
D/D |
11,000 |
158,149 |
2.81 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2009-05-14 |
4 |
B |
$2.07 |
$41,400 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| ZGEN |
Zymogenetics Inc |
President & CEO |
• • – |
2004-06-21 |
4 |
D |
$17.16 |
$415,289 |
D/D |
(24,201) |
131,299 |
|
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
